LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • IDEAYA Biosciences And Hengrui Pharma Present Positive Phase 1 Data For IDE849 In Small Cell Lung Cancer 9/7/2025 12:04:58 PM
  • IDEAYA Biosciences Enrolls First-Patient-In For Phase 1/2 Combination Trial Of IDE397 And Trodelvy 9/4/2025 6:04:17 AM
  • IDEAYA Biosciences Announces IND Submission For IDE892 For MTAP-Deletion Solid Tumors 9/3/2025 6:30:42 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/29/2025 6:01:24 AM
  • IDEAYA Biosciences Q2 Loss/shr Widens To $0.88 From $0.82 Last Year 8/5/2025 6:10:30 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/1/2025 6:15:48 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6/27/2025 6:05:09 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 5/30/2025 6:04:11 AM
  • IDEAYA Biosciences Posts Q1 Net Loss Of $72.2 Mln Vs. Net Loss Of $133.3 Mln Last Quarter 5/6/2025 6:12:46 AM
  • IDEAYA Announces FDA IND-Clearance For IDE849 For Phase 1 Study In Solid Tumors 5/6/2025 6:12:09 AM
  • IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 4/25/2025 6:01:31 AM
  • IDEAYA Biosciences Announces FDA Type D Meeting On Phase 3 Registrational Trial Design For Darovasertib 4/14/2025 6:09:12 AM
  • IDEAYA Biosciences Begins Phase 1/2 Expansion For IDE397 And Trodelvy Combination In MTAP-Deletion Urothelial Cancer 4/10/2025 6:01:34 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap